Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-021563

VP Finance & Operations sold 450 shares at an average $0.50 ($225)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mitrano Richard J. · VP Finance & Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-27 Sale : show line 1 in the form 10b5-1 −227 $0.53 $120 52,418 D
2023-07-28 Sale : show line 2 in the form 10b5-1 −223 $0.47 $105 52,195 D
Open-market sales · 450 sh · avg $0.50 · $225
Loading xslF345X05/form4.xml…